All In MedTech

Device Trial Radar · NCT06376032

EndeavorOTC® Research Study in College Students

Last checked: Nov 19, 2026Latest source record: Jun 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

69

Actual

Start

Jan 10, 2024

Primary completion

Dec 31, 2025

Study completion Dec 31, 2025

Sponsor

Lead sponsor
Akili Interactive Labs, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Landmark College; Villa Maria College
First posted
Apr 19, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the impact of a digital therapeutic (EndeavorOTC®, also known as AKL-T01A) on clinical symptoms of executive and cognitive functioning in a real-world sample of university students. This study aims to answer whether EndeavorOTC represents a useful intervention for targeting broad cognitive and emotional health among university students.

Conditions

  • Attention
  • Cognition
  • University Students

Interventions

  • EndeavorOTC®Device

    EndeavorOTC is an over the counter digital therapeutic designed to improve attention function as measured by computer-based testing in patients 18 and older with primarily inattentive or combined type ADHD, who have a demonstrated attention issue. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx®, an FDA-authorized prescription digital therapeutic indicated to improve attention function in children ages 8-17. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Computerized Adaptive Test, Mental Health (CAT-MH®)Time frame: Baseline, Exit (Day 84)
  2. PROMIS Cognitive Function v2.0 - Short FormTime frame: Baseline, Day 42, Day 84
  3. PROMIS Satisfaction with Participation in Discretionary Social Activities (v1.0)Time frame: Baseline, Day 42, Day 84

4 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Villa Maria College

    Cheektowaga, New York

  • Landmark College

    Putney, Vermont

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.